Jacob Glanville
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$3.2MFederal grants as PI4 awards
1Patents grantedLatest Jan 27, 2026
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
4 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Aug 14, 2025 | NIH | SBIR Phase II Development of World's First Fully Human Broad Spectrum Anti-Snake Venom | $997K | Centivax Inc |
| Jul 25, 2024 | NIH | SBIR Phase II Development of World's First Fully Human Broad Spectrum Anti-Snake Venom | $996K | Centivax Inc |
| Aug 16, 2023 | NIH | SBIR Phase II Development of World's First Fully Human Broad Spectrum Anti-Snake Venom | $996K | Centivax Inc |
| Jan 12, 2021 | DoD | SBIR Phase I Development of Human Monoclonal Antibody Therapeutic against Klebsiella pneumoniae Infection | $250K | Centivax Inc |
2 patents as inventor
- US 12534513Centivax IncJan 27, 2026
- US Centivax Inc—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#549
Awards as PI#566
Patents#155
Companies
- Centivax IncLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.